S
PRME icon

SignatureFD’s Prime Medicine PRME Stock Holding History

SignatureFD’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4K Hold
5,000
– – ﹤0.01% 2264
2025
Q4 		$17.4K Hold
5,000
– – ﹤0.01% 2183
2025
Q3 		$27.7K Buy
5,000
+4,000
+400% +$16.3K ﹤0.01% 1954
2025
Q2 		$2.47K Sell
1,000
-1,649
-62% -$2.54K ﹤0.01% 2815
2025
Q1 		$5.27K Buy
2,649
+996
+60% +$2.54K ﹤0.01% 2586
2024
Q4 		$4.83K Buy
1,653
+243
+17% +$853 ﹤0.01% 2619
2024
Q3 		$5.46K Buy
1,410
+410
+41% +$1.9K ﹤0.01% 2546
2024
Q2 		$5.14K Buy
+1,000
New +$6.06K ﹤0.01% 2505

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SignatureFD's PRME Position: Q1 2026 in Review

SignatureFD held its Prime Medicine (PRME) position steady in Q1 2026 at 5,000 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

SignatureFD first reported a position in PRME in Q2 2024 and has held it in 8 quarters since. The position peaked at $27.7K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • SignatureFD held 5,000 shares of Prime Medicine worth $17.4K as of Q1 2026.
  • SignatureFD left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2264 holding.
  • SignatureFD first reported a position in Prime Medicine in Q2 2024 and has held it in 8 quarters since.
  • SignatureFD's Prime Medicine position peaked at $27.7K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.